← Leaderboards
Nicole Jackson
Bioamp Diagnostics, Inc.
$323,115
Attributed
$323,115
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $243.8K · FY2024–25$250K$187.5K$125K$62.5K$0
'24
'25
Funding mix
By agency
NIH$323,115 · 1
By mechanism
R43$323,115 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Acinetobacter Baumannii”
- Justin Blaine Schaal · University Of Southern California$3,025,760
- Paul Sebahar · Curza Inc$2,858,436
- Tsuyoshi Uehara · Venatorx Pharmaceuticals, Inc.$2,000,000
- Yanan Zhao · State University Of New York At Buffalo$1,596,741
- Despoina Mavridou · University Of Texas At Austin$1,558,092
- Vidmantas Petraitis · Hackensack University Medical Center$1,428,749
Research focus
Acinetobacter BaumanniiAntibiotic SusceptibilityAnti-Microbial SusceptibilityAssay DevelopmentBeta-LactamaseBeta-LactamsBiochemicalBoronic AcidsCarbapenemaseCarbapenem ResistanceCarbapenemsCare DeliveryCellsClassificationClavulanic AcidsContainmentCostCytolysisDeath RateDesignDetectionDiagnosticDiagnostic TestsAcceleration
Grant awards (2)
Evolving the standard of care for carbapenem resistant infections, through the development of a phenotypic assay capable of DETECTing and classifying carbapenemases$79,309
R43 · FY2025 · AI · contact PI
Evolving the standard of care for carbapenem resistant infections, through the development of a phenotypic assay capable of DETECTing and classifying carbapenemases$243,806
R43 · FY2024 · AI · contact PI